Should You Buy China Evergrande Group (3333.HK) During Its Liquidity Uncertainty?
On 20 July 2021, the world’s most indebted developer China Evergrande Group (3333.HK) closed at HKD 7.37 which downed by 10.23%. The share price plunged by 23% since the started of pre-litigation asset preservation process from China Guangfa Bank Yixing…
Is DiDi Global Inc. (DIDI) A Buy After App Takedown in China?
On 4 July 2021, DiDi Global Inc. (DIDI) announced that according to the announcement posted by the Cyberspace Administration of China (the “CAC”) on July 4, 2021, the CAC stated that it was reported and confirmed that the “DiDi Chuxing”…
Should You Add Medlive Technology Co., Ltd. (2192.HK) In Your Portfolio?
Medlive Technology Co., Ltd. (2192.HK) started its IPO on 30 June 2021 with indicative offer price range between HKD 24.1 to HKD 27.2. Medlive Technology will start its trading in Hong Kong Stock Exchange on 15 July 2021. Should investors…
Recent Comments